Oncodesign Precision Medicine Société anonyme (ENXTPA:ALOPM) acquired Zobio B.v. on January 23, 2024.

Oncodesign Precision Medicine Société anonyme (ENXTPA:ALOPM) completed the acquisition of Zobio B.v. on January 23, 2024. Guillaume Briant, and Evelyne Bagdassarian of Stephenson Harwood, Carine Van Den Brink of Axon Advocaten, Arjan Bisseling, Omer Yalcin and Thijs de Wilde of AsjesBisseling acted as Accountant to shareholders of ZoBio. Alexandre Kaplan, Elia Laurent and Nicolas Vacher of Altios France acted as financial advisor and Henri Pieyre de Mandiargues, Côme de Saint-Vincent of McDermott Will & Emery LLP acted as legal advisor to Oncodesign Precision Medicine Société anonyme.